OVERVIEW
COMMITMENT TO INNOVATION
WATCHMAN LAAC THERAPY
TAVR PORTFOLIO
EDUCATIONAL RESOURCES
WATCHMAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE

WATCHMAN LEFT ATRIAL
APPENDAGE CLOSURE DEVICE


The one-time procedure that may provide a lifetime of stroke risk reduction in NAVF patients who need an alternative.
 
 

AN END TO LONG-TERM WARFARIN


After receiving the WATCHMAN Implant, 92% of patients were able to stop taking warfarin in 45 days; 99% were able to stop warfarin in 1 year1

 

72 percent image

WATCHMAN patients experienced a 72% reduction in major bleeding events vs warafin beyond 6 months post procedure 

(1.0 vs 3.5 events per 100 patient-years; RR=0.28, P<0.001)2

A PROVEN PROCEDURE WITH PROVEN SAFETY
WATCHMAN delivers positive results in multiple clinical trials.

A PROVEN PROCEDURE WITH PROVEN SAFETY


WATCHMAN delivers positive results in multiple clinical trials. Learn more about the efficacy and safety data.
WHO WATCHMAN IS FOR
See which of your patients may be eligible for the WATCHMAN therapy.

WHO WATCHMAN IS FOR


See which of your patients may be eligible for the WATCHMAN therapy.

VISIT THE WATCHMAN WEBSITE TO SEE HOW WATCHMAN IS IMPLANTED


WATCHMAN device

WATCHMAN™ & LAAC EDUCATIONAL OFFERINGS


Boston Scientific offers robust technical training and support for new and established WATCHMAN programs. 

  • WATCHMAN U technical training program for implanters
  • Clinical Coordinator training program

 

In addition, we offer LAAC therapy education available for all HCPs.

 
Join our community to receive updates and help us advance the treatment of structural heart therapies.

BE PART OF OUR VISION


We take partnership to heart. 
Join our community to receive updates and help us advance the treatment of structural heart therapies.
Top